1. Risk Assessment:

Based on the ACC/AHA guidelines, the patient has several risk factors for cardiovascular disease: 

- Age: Being over 55 for a male is considered a risk factor.
- High Blood Pressure: The patient's blood pressure is 164 mm Hg, which is classified as Stage 2 Hypertension. 
- High Fasting Blood Sugar: This could indicate diabetes, another risk factor for CVD.
- Chest Pain Type: Typical angina is often associated with coronary artery disease.
- Number of Major Vessels: Having 2 major vessels involved also increases the risk.

On the other hand, the patient has a normal cholesterol level, a normal heart rate, no exercise-induced angina, and normal thalassemia, which are positive factors. The AI models predict a low CVD risk with high confidence, but these predictions seem to contradict the guideline-based risk assessment due to the above-mentioned risk factors.

2. Treatment Recommendations:

The patient's blood pressure should be managed aggressively with lifestyle modifications and potentially antihypertensive medication, aiming for a target BP of less than 130/80 mm Hg. 

Lifestyle modifications should include a heart-healthy diet, regular exercise, avoidance of tobacco, and moderation of alcohol. 

As for the high fasting blood sugar, it should be managed with lifestyle changes and potentially hypoglycemic agents, aiming for an HbA1c level of less than 7.0%.

3. Monitoring Plan:

The patient should have regular follow-up appointments every 3-6 months to monitor blood pressure, cholesterol level, heart rate, and blood sugar levels. If these parameters do not improve or worsen, additional testing (like stress testing or coronary angiography) or specialist referral (to a cardiologist or endocrinologist) may be considered.

4. Special Considerations:

Given the patient's age and gender, he is at an increased risk of cardiovascular disease. Therefore, aggressive risk factor management is crucial. The patient should also be screened for potential contraindications to certain treatments, such as beta-blockers if the patient has asthma. Co-management with a diabetologist may be necessary if blood sugar levels remain high. 

In conclusion, while the AI models predict low CVD risk, the guideline-based assessment suggests a higher risk, which should be managed appropriately.